Abstract
Effects on linear growth were noted in children treated with peginterferon ± ribavirin in the Pediatric Study of Hepatitis C trial. Growth was further examined in a subset of patients followed for up to 6 years post-treatment. No long-term effects on height-for-age z scores were observed that could be attributed to hepatitis C virus treatment.
Original language | English (US) |
---|---|
Pages (from-to) | 1252-1254 |
Number of pages | 3 |
Journal | Journal of Pediatrics |
Volume | 165 |
Issue number | 6 |
DOIs | |
State | Published - Dec 1 2014 |
Keywords
- HAZ Height-for-age z score LTFU Long-term follow-up PEG-IFN Peginterferon RBV Ribavirin
ASJC Scopus subject areas
- Pediatrics, Perinatology, and Child Health